Regenerative Medicine for Periodontal and Peri-implant Diseases
- PMID: 26608580
- PMCID: PMC4766955
- DOI: 10.1177/0022034515618887
Regenerative Medicine for Periodontal and Peri-implant Diseases
Abstract
The balance between bone resorption and bone formation is vital for maintenance and regeneration of alveolar bone and supporting structures around teeth and dental implants. Tissue regeneration in the oral cavity is regulated by multiple cell types, signaling mechanisms, and matrix interactions. A goal for periodontal tissue engineering/regenerative medicine is to restore oral soft and hard tissues through cell, scaffold, and/or signaling approaches to functional and aesthetic oral tissues. Bony defects in the oral cavity can vary significantly, ranging from smaller intrabony lesions resulting from periodontal or peri-implant diseases to large osseous defects that extend through the jaws as a result of trauma, tumor resection, or congenital defects. The disparity in size and location of these alveolar defects is compounded further by patient-specific and environmental factors that contribute to the challenges in periodontal regeneration, peri-implant tissue regeneration, and alveolar ridge reconstruction. Efforts have been made over the last few decades to produce reliable and predictable methods to stimulate bone regeneration in alveolar bone defects. Tissue engineering/regenerative medicine provide new avenues to enhance tissue regeneration by introducing bioactive models or constructing patient-specific substitutes. This review presents an overview of therapies (e.g., protein, gene, and cell based) and biomaterials (e.g., resorbable, nonresorbable, and 3-dimensionally printed) used for alveolar bone engineering around teeth and implants and for implant site development, with emphasis on most recent findings and future directions.
Keywords: 3D printing; alveolar bone; gene therapy; growth factors; regeneration; tissue engineering.
© International & American Associations for Dental Research 2015.
Conflict of interest statement
The remaining authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.
Figures




References
-
- Agarwal A, Gupta ND, Jain A. 2016. Platelet rich fibrin combined with decalcified freeze-dried bone allograft for the treatment of human intrabony periodontal defects: a randomized split mouth clinical trail. Acta Odontol Scand. 74(1):36–43. - PubMed
-
- Aghazadeh A, Rutger Persson G, Renvert S. 2012. A single-centre randomized controlled clinical trial on the adjunct treatment of intra-bony defects with autogenous bone or a xenograft: results after 12 months. J Clin Periodontol. 39(7):666–673. - PubMed
-
- Bartold PM, Gronthos S, Ivanovski S, Fisher A, Hutmacher DW. 2016. Tissue engineered periodontal products. J Periodontal Res. 51(1):1–15. - PubMed
-
- Bertram TA, Johnson PC, Tawil BJ, Van Dyke M, Hellman KB. 2015. Enhancing tissue engineering/regenerative medicine product commercialization: the role of science in regulatory decision making for TE/RM product development. Tissue Eng Part A. 21(19–20):2476–2479. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources